In a patient with worsening leukocytosis (white blood cell count increasing from 14 to 20 ×10⁹/L), recent piperacillin‑tazobactam (Zosyn) and amoxicillin‑clavulanate (Augmentin) for aspiration pneumonia, Escherichia coli/Proteus urinary tract infection treated with fosfomycin, CT evidence of enteritis, stool collected for Clostridioides difficile, and chronic tube feeding, what is the appropriate infectious disease management?

Management of Worsening Leukocytosis in a Tube-Fed Patient with Recent Broad-Spectrum Antibiotic Exposure

Stop all current antibiotics immediately and initiate empiric treatment for Clostridioides difficile infection (CDI) with oral vancomycin 125 mg four times daily while awaiting stool test results. The clinical picture—worsening leukocytosis (WBC 14→20) despite sequential broad-spectrum antibiotics (piperacillin-tazobactam, amoxicillin-clavulanate), CT evidence of enteritis, and chronic tube feeding—strongly suggests antibiotic-associated CDI as the primary driver of clinical deterioration 1.

Primary Diagnosis: Presumptive C. difficile Infection

The constellation of findings makes CDI the most likely diagnosis:

• Recent broad-spectrum antibiotic exposure (Zosyn followed by Augmentin) is the strongest risk factor for CDI
• CT enteritis provides radiographic support for colonic inflammation
• Tube feeding is an independent risk factor for CDI, as continuous enteral nutrition alters gut microbiota and increases susceptibility 2
• Progressive leukocytosis (WBC 20) meets criteria for severe CDI (WBC >15,000) per IDSA guidelines 1

Start vancomycin 125 mg orally (or via feeding tube) four times daily for 10 days immediately—do not wait for stool test results. If the patient cannot tolerate oral/enteral administration due to ileus, add IV metronidazole 500 mg every 8 hours 1. Fidaxomicin is preferred over vancomycin per guidelines, but vancomycin remains the standard alternative and is more widely available 1.

Secondary Consideration: Drug-Induced Leukocytosis

Piperacillin-tazobactam can cause paradoxical leukocytosis as an adverse drug reaction 3, 4, 5. However, this typically:

• Occurs during active drug administration (not after discontinuation)
• Resolves within days of stopping the medication
• Is not associated with CT enteritis

Since Zosyn was already discontinued (switched to Augmentin), drug-induced leukocytosis is less likely but should be considered if leukocytosis persists after treating CDI.

Antibiotic Stewardship: Stop Unnecessary Antibiotics

Discontinue Augmentin immediately. The patient has already received appropriate treatment courses for:

• Aspiration pneumonia: Adequately treated with Zosyn, then Augmentin (amoxicillin-clavulanate is first-line for aspiration pneumonia) 6
• UTI (E. coli/Proteus): Treated with fosfomycin, which provides single-dose coverage

Continuing antibiotics without clear ongoing infection perpetuates CDI risk and promotes resistance. The worsening leukocytosis despite antibiotics suggests the antibiotics themselves are the problem, not the solution 7.

Addressing the Enteritis

The CT finding of enteritis in this context most likely represents:

1. CDI-associated colitis (most probable)
2. Tube feeding-related enteritis (less likely given leukocytosis)
3. Ischemic enteritis (consider if patient has vascular risk factors)

The temporal relationship with antibiotic exposure and leukocytosis strongly favors CDI.

Monitoring and Follow-Up

While awaiting C. difficile toxin results:

• Monitor WBC daily: Expect improvement within 48-72 hours if CDI is the cause
• Assess clinical response: Decreased stool frequency, resolution of fever, improved abdominal exam
• Check serum creatinine and albumin: Hypoalbuminemia and rising creatinine predict worse CDI outcomes 2

If WBC continues rising despite vancomycin, consider:

• Fulminant CDI: Escalate to vancomycin 500 mg four times daily + IV metronidazole; surgical consultation 1
• Alternative diagnosis: Intra-abdominal abscess, ischemic bowel, malignancy (though less likely given acute presentation)

Tube Feeding Optimization

Switch to continuous feeding if currently intermittent. Continuous enteral feeding is associated with milder diarrhea severity in CDI patients compared to intermittent bolus feeding (OR 7.91, p<0.001) 2. This also improves biochemical stability and electrolyte management.

Common Pitfalls to Avoid

1. Do not add more antibiotics: The reflex to escalate antibiotics for rising WBC often worsens CDI
2. Do not use metronidazole monotherapy: Metronidazole is inferior to vancomycin for CDI and should only be used when vancomycin/fidaxomicin are unavailable 1
3. Do not stop tube feeds: Nutritional support should continue; adjust feeding strategy rather than discontinue 2
4. Do not attribute leukocytosis to "persistent inflammation": While PICS (persistent inflammation-immunosuppression-catabolism syndrome) exists in trauma/ICU patients 7, this patient's acute worsening with antibiotic exposure points to active CDI

If C. difficile Testing is Negative

If stool tests return negative but clinical suspicion remains high:

• Repeat testing: Single negative test does not exclude CDI (sensitivity ~85-90%)
• Consider empiric treatment completion: If clinical improvement on vancomycin, complete the 10-day course
• Reassess for alternative diagnoses: Small bowel bacterial overgrowth, medication effect, inflammatory bowel disease

The key principle: In a patient with worsening leukocytosis, recent broad-spectrum antibiotics, enteritis, and tube feeding, CDI is the diagnosis until proven otherwise—treat empirically while awaiting confirmation 1.